covid 19 at USA



Objectives

The paper highlights US health policy and technology responses to the COVID-19 pandemic from January 1, 2020 – August 9, 2020.

Methods

A review of primary data sources in the US was conducted. The data were summarized to describe national and state-level trends in the spread of COVID-19 and in policy and technology solutions.

Results

COVID-19 cases and deaths initially peaked in late March and April, but after a brief reduction in June cases and deaths began rising again during July and continued to climb into early August. The US policy response is best characterized by its federalist, decentralized nature. The national government has led in terms of economic and fiscal response, increasing funding for scientific research into testing, treatment, and vaccines, and in creating more favorable regulations for the use of telemedicine. State governments have been responsible for many of the containment, testing, and treatment responses, often with little federal government support. Policies that favor economic re-opening are often followed by increases in state-level case numbers, which are then followed by stricter containment measures, such as mask wearing or pausing re-opening plans

Comments

Post a Comment

Popular posts from this blog

Image
 How to safe covid 19 Important Ways to Slow the Spread Wear a mask that covers your nose and mouth to help  protect  yourself and others. Stay 6 feet apart from others who don't live with you. Get a  COVID - 19  vaccine when it is available to you. Avoid crowds and poorly ventilated indoor spaces. Wash your hands often with soap and water.
Read more
Image
Managing the supportive care needs of those affected by COVID-19 Globally, the number of people affected by coronavirus disease 2019 (COVID-19) is rapidly increasing. In most (>80%), the illness is relatively mild and can be self-managed out of hospital. However, for about 20%, the illness causes respiratory compromise severe enough to require hospital admission [ 1 ]. Patients with severe and critical disease need full active treatment. This may include oxygen for hypoxaemia and ventilatory support, along with optimal management of complications,  e.g.  super-imposed bacterial infection, and any underlying comorbidities,  e.g.  COPD or congestive heart failure. To date, no antiviral agent has shown to be effective in treating the disease [ 2 ]. Patients with severe disease not considered suitable for escalation to intensive care,  i.e.  those who are frail or have multiple comorbidities, are at very high risk of dying, with an estimated death rate of 15...
Read more
Image
 covid 19 updates until 12.05.2021 Coronavirus Cases: 160,344,804 Deaths: 3,331,866 Recovered: 138,124,411
Read more